Metabolic Alkalosis: Chloride, Potassium, and Renal Mechanisms

Metabolic alkalosis requires an explanation of what generated the disturbance and what prevents its disposal. Gastric losses, diuretics, alkali input, chloride availability, potassium balance, filtration, and distal transport contribute in different combinations. The initiating process may have stopped while the mechanisms maintaining the increased bicarbonate state remain active.

55.1 Generation and Maintenance Describe Different Parts of the Process

Metabolic alkalosis is an alkalinizing process, while alkalemia describes the measured blood pH being above the relevant reference range. The process can coexist with respiratory or metabolic acidifying influences, so its presence does not require a conspicuously high pH. Conversely, an increased bicarbonate concentration can participate in adaptation to sustained carbon dioxide retention rather than identify an isolated primary metabolic disturbance.

The familiar plasma relation provides the immediate chemical context:

Bicarbonate concentration is in mmol/L and arterial carbon dioxide partial pressure, PaCO₂, in mmHg. The approximate coefficient of 0.03 mmol/L/mmHg converts pressure to dissolved carbon dioxide concentration at the assumed 37°C conditions. The 6.1 term is the apparent pK′ under these conditions. The ratio describes a state; it does not identify the cause or establish an expected compensation rule.

Generation may involve loss of acid, gain of base or a metabolizable base precursor, or changes in electrolyte and water balance that favor an alkalinizing state. Renal hydrogen secretion and redistribution between extracellular and intracellular buffers can contribute. These routes must be assessed with their associated ions and external balances rather than treated as identical additions to a single bicarbonate tank.

Maintenance concerns why the kidney does not dispose of the excess bicarbonate appropriately for the overall state. Reduced filtered delivery, increased reclamation, continuing net acid excretion, impaired bicarbonate secretion, and the prevailing chloride and potassium conditions can all contribute. An intact kidney under suitable conditions can excrete an alkali load; persistent accumulation therefore requires an explanation of supply relative to disposal.

The same exposure can affect both phases. A diuretic can generate losses and simultaneously create chloride, potassium, and circulatory conditions that sustain alkalosis after its direct effect wanes. Gastric drainage can stop before renal handling has returned to its earlier state.

Knowing that vomiting occurred does not establish whether continuing losses, altered transport, or another process now dominates. The present state and trajectory still require explanation.

55.2 Gastric Acid Loss Changes More Than Water Volume

Gastric parietal cells secrete hydrogen ions into the lumen while bicarbonate enters the blood. During ordinary digestion, subsequent intestinal secretion and absorption integrate that transient redistribution into overall balance. Removing gastric hydrochloric acid from the body interrupts the usual sequence and represents a net acid loss.

The amount depends on actual fluid composition and volume, not the visual presence of a drainage bag. For an illustrative measured gastric loss of 1 L containing 80 mmol/L of acid equivalents, acid loss is 1 × 80 = 80 mmol. The assumed composition is not a universal gastric concentration. It cannot be converted directly into the change in serum bicarbonate or a replacement requirement.

Sodium, potassium, chloride, and water accompany gastric drainage in variable amounts. Their loss affects extracellular distribution and renal conservation signals. Secondary urinary potassium loss can exceed the potassium directly removed from the stomach, so the composition of the initial loss does not describe all subsequent deficits.

Needle, Kaloyanides, and Schwartz selectively depleted hydrochloric acid by gastric drainage in dogs while replacing the measured sodium, potassium, and water withdrawn. Persistent alkalosis developed under chloride-restricted conditions. This controlled preparation demonstrated an acid-and-chloride pathway beyond simply removing those other gastric constituents; it was not a human treatment protocol. 1

During an early phase with bicarbonate reaching urine, urinary sodium can be appreciable because it accompanies bicarbonate rather than chloride. Later, sodium conservation and distal acid secretion can intensify despite systemic alkalemia. Acidic urine in that setting is therefore not logically incompatible with metabolic alkalosis.

Continued vomiting or suction supplies an ongoing generator, but persistence after drainage stops asks a different question. The remaining chloride and potassium deficits, filtration, effective arterial filling, and distal transport determine whether retained bicarbonate can be eliminated.

Other gastrointestinal losses need their own composition-based interpretation. Many intestinal losses remove bicarbonate and favor acidosis, while selected chloride-rich losses can have an alkalinizing effect. Calling a process gastrointestinal does not determine its acid–base direction without identifying what was lost.

55.3 Diuretics Couple Salt Loss to Distal Acid and Potassium Handling

Loop and thiazide-type drugs reduce sodium chloride reabsorption at different nephron sites. The resulting increase in downstream sodium delivery can favor electrogenic sodium absorption through epithelial sodium channels, or ENaC. This electrical environment supports potassium secretion and interacts with distal hydrogen secretion.

Renal acid–base consequences depend on more than delivery alone. Aldosterone signaling, potassium availability, chloride balance, functioning nephron mass, and tubular flow alter the result. An increase in net acid excretion adds bicarbonate equivalents to the body, while enhanced reclamation prevents loss of existing filtered bicarbonate. These are distinct contributions, as developed in Chapter 52.

Salt and water loss can reduce effective arterial filling and stimulate renal conservation. Chloride and potassium depletion can then maintain the alkalotic state even when the direct drug effect has ended. Continued diuretic exposure may therefore be a generator, while the state it created becomes an additional maintenance mechanism.

The urine pattern changes across the interval. During active salt transport inhibition, chloride excretion may be substantial. As the drug effect wanes, strong sodium chloride conservation can follow. Wilcox and colleagues' controlled furosemide balance experiments in healthy subjects demonstrated that compensatory retention between drug effects could offset acute sodium losses. This temporal behavior cautions against treating one sample as a permanent renal phenotype. 2

A patient can consequently be chloride depleted while excreting chloride during the active phase. A later low urinary chloride does not prove that the preceding exposure was absent. Drug timing, current intake, and matched urine flow are necessary for interpreting the observation.

The underlying disease also matters. In heart failure, persistent congestion can coexist with conservation signals and limited effective arterial filling. An alkalotic, edematous patient does not necessarily have the same tolerance of added sodium and water as a patient with uncomplicated external volume loss.

Diuretic-associated alkalosis is therefore an integrated transport and balance response. Neither the drug name nor its administered amount identifies the current chloride deficit, potassium deficit, intravascular volume, or safest point for changing the physiology.

55.4 Extracellular Volume and Filtration Contribute Without Explaining Everything

Loss of bicarbonate-poor salt and water can increase bicarbonate concentration within a contracting extracellular space. This concentration effect does not describe the complete renal response. The amount retained, the accompanying ions, buffer exchange, and changes in water distribution must also be considered.

Reduced effective arterial filling can increase proximal sodium and bicarbonate reclamation through neurohumoral and peritubular mechanisms. Angiotensin signaling and the forces favoring proximal uptake can reduce the bicarbonate and sodium reaching later segments. These responses can persist despite a bicarbonate concentration that would otherwise favor increased urinary disposal.

A reduction in glomerular filtration rate, or GFR, lowers the filtered bicarbonate amount at a given plasma concentration:

Use GFR in L/day and concentration in mmol/L to obtain mmol/day. With illustrative GFR of 100 mL/min and bicarbonate 36 mmol/L, filtration is 0.100 × 1,440 = 144 L/day, giving 144 × 36 = 5,184 mmol/day. At GFR of 60 mL/min with the same concentration, the load is 0.060 × 1,440 × 36 = 3,110.4 mmol/day.

Less bicarbonate is then presented for potential excretion even without an increased absolute reabsorptive rate. The approximation uses plasma concentration for the filterable fraction and does not calculate actual reabsorption, distal secretion, or net base balance.

Cogan and Liu studied alkalotic rats with micropuncture and clearance methods. Their preparation showed reduced filtration with a relatively preserved filtered bicarbonate load despite an increased concentration, supporting a filtration-mediated maintenance mechanism. This identifies one experimental route; it does not establish that reduced GFR is necessary for every human metabolic alkalosis. 3

These pathways explain why circulatory underfilling can matter. They do not make all alkalosis a contraction disorder or establish that volume expansion alone will correct it. Persistent chloride limitation, potassium depletion, distal signaling, or continued alkali input can remain important even when filtration or apparent volume improves.

55.5 Chloride Availability Has Renal Effects Beyond Expansion

Chloride is part of renal transport and acid–base regulation, rather than simply an indicator of how much extracellular water has been lost. Its availability influences which anions accompany sodium reabsorption and whether distal bicarbonate secretion can proceed effectively. Total-body chloride balance, plasma concentration, and chloride delivery to a particular segment are related but different quantities.

A low serum chloride can reflect depletion, altered water balance, or the accompanying acid–base composition. It must be interpreted relative to sodium and the other ions, as explained in Chapter 53. Conversely, a circulating concentration cannot by itself certify adequate chloride delivery to a bicarbonate-secretory transporter.

Galla and colleagues compared chloride administration with albumin-mediated expansion in experimentally chloride-depleted alkalotic rats. Expansion increased plasma volume without correcting the alkalosis, whereas chloride corrected it despite continued contraction and lower filtration. The preparation separates chloride and expansion effects under controlled conditions; it does not imply that circulatory volume is irrelevant in clinical illness. 4

Rosen and colleagues studied furosemide-induced chloride-depletion alkalosis in healthy men. Chloride repletion was accompanied by increased bicarbonate excretion and correction despite persistent reductions in plasma volume, GFR, and renal plasma flow. A comparison condition with sodium depletion but no chloride depletion did not show the same acid–base response. The findings support a chloride-specific renal contribution without establishing a universal fluid or electrolyte prescription. 5

The studies also caution against interpreting every response to a chloride-containing fluid as proof that volume expansion was the active component. Such an intervention usually changes several variables simultaneously. Conversely, failure to correct after one intervention may reflect continued losses, impaired delivery, or other maintenance mechanisms rather than disprove the importance of chloride.

Chloride depletion and reduced effective arterial filling commonly coexist, but the causal explanation improves when they are kept distinguishable. One changes available substrate and transport relationships; the other changes conservation signals, perfusion, and filtration. Their combination can be more consequential than either alone.

55.6 Pendrin Connects Chloride Conservation with Bicarbonate Secretion

Distal intercalated cells can support acid or bicarbonate secretion through different membrane arrangements. Acid-secreting type A cells place proton pumps toward the lumen and return bicarbonate toward blood. Bicarbonate-secreting type B cells use an apical chloride–bicarbonate exchange pathway, with proton transport arranged toward the opposite side.

Pendrin, encoded by SLC26A4, contributes to the apical exchange of luminal chloride for cellular bicarbonate. In this simplified functional description, chloride enters the cell while bicarbonate enters urine. The process therefore links chloride conservation with disposal of base; it does not require that chloride be a freely administered acid.

Royaux and colleagues localized pendrin in intercalated-cell populations in mouse, rat, and human kidney. In their functional experiments, isolated cortical collecting ducts from alkali-loaded wild-type mice secreted bicarbonate, whereas ducts from pendrin-knockout mice failed to do so. The study established an important transport contribution, with the causal functional experiment performed in mice rather than patients. 6

Insufficient luminal chloride can limit exchange even if the transporter is present. Conversely, transporter abundance and membrane localization can change, so adequate plasma chloride does not ensure normal secretory capacity. Flow, upstream reabsorption, hormonal signaling, and potassium status modify the conditions reaching these cells.

The collecting duct is not a single switch that uniformly reverses all transport when blood pH rises. Different cell populations and neighboring sodium pathways respond to integrated signals. A state favoring sodium conservation or potassium recovery may continue to support acid secretion while other cells could dispose of bicarbonate.

This organization helps explain persistence: a high circulating bicarbonate concentration is a stimulus within a system whose transport opportunities may remain constrained. It also explains why describing chloride merely as replacing lost volume misses an identifiable cellular mechanism.

Proximal bicarbonate handling, filtration, ammonium metabolism, and other distal pathways also contribute. Pendrin does not explain every chloride-associated alkalosis by itself, and an isolated urine measurement cannot assay its function.

55.7 Potassium Depletion Can Favor Alkalosis Through Several Routes

Potassium balance influences acid–base physiology through cellular distribution and renal adaptation. Potassium depletion can favor intracellular acidification in some tissues while extracellular conditions become more alkaline. However, this cannot be represented as a fixed one-for-one exchange between all cellular potassium and hydrogen ions.

Renal responses can include increased bicarbonate reclamation, altered ammonium production, and changes in collecting-duct acid and bicarbonate transport. Potassium-conserving hydrogen–potassium exchange provides one distal connection. These effects depend on the potassium deficit, dietary and hormonal context, chloride supply, and the kidney's functioning transport capacity.

Jones and colleagues induced dietary potassium depletion in healthy men without changing dietary anion content. A small sustained alkalinizing change developed without chloride depletion or mineralocorticoid excess. Net acid excretion nevertheless fell slightly in their observed steady state. This demonstrates a potassium contribution while cautioning against assuming that every potassium-depletion alkalosis requires persistently increased net acid excretion. 7

More recent mouse experiments by Lee and colleagues linked hypokalemia to changes in collecting-duct intercalated-cell phenotype, acid-secretory protein localization, and reduced pendrin abundance. Deleting the proximal electrogenic sodium–bicarbonate cotransporter NBCe1-A blunted many acid-secretory responses, suggesting communication between proximal and distal segments. Reduced pendrin persisted despite that deletion, indicating a different dependence for this response. Ammonia was a proposed mediator of proximal-to-distal signaling, not conclusively established as the only signal. 8

These experiments add depth to the usual explanation of cellular hydrogen shifts. Sustained changes involve transport and signaling rather than only passive redistribution. The precise response in a critically ill human cannot be read directly from a mouse diet or one serum potassium result.

The relationship also runs in the other direction. Alkalemia and the associated distal delivery or hormonal state can promote extracellular potassium decline and renal losses. Magnesium deficiency may help sustain potassium wasting, as explained in Chapter 46. These feedbacks can maintain a combined disturbance.

Potassium depletion is therefore mechanistically important without being universally sufficient or necessary. Correcting one contributor may leave chloride limitation, low filtration, ongoing losses, or mineralocorticoid effects intact. Mechanism identifies what needs assessment; it does not calculate a replacement dose from the bicarbonate concentration.

55.8 Mineralocorticoid and ENaC Effects Depend on the Transport Context

Mineralocorticoid signaling increases the capacity for distal sodium absorption and can promote potassium and hydrogen loss. Sodium entry through ENaC helps establish the electrical environment supporting secretion, while intercalated-cell transport and potassium depletion contribute additional acid–base effects. Sufficient sodium delivery and functioning transport pathways are required for these signals to produce their full effect.

In reduced effective arterial filling, aldosterone can be an appropriate conservation response accompanying chloride and water loss. In autonomous mineralocorticoid states, continued signaling can sustain sodium retention and potassium depletion despite expanded extracellular volume. Similar electrolyte patterns can therefore arise from different circulatory starting points.

Kassirer and colleagues studied experimentally induced alkalosis in human volunteers. Increased aldosterone secretion was not required for its development, and chloride-containing repletion could reduce alkalosis despite continued steroid exposure and persistent potassium depletion. These findings show that hormone signaling, chloride availability, and potassium balance cannot be assigned fixed independent effects from a single measurement. 9

A mineralocorticoid-like phenotype also need not arise from excessive circulating aldosterone. Constitutively increased ENaC activity can promote sodium retention and a potassium-wasting environment downstream. Schild and colleagues expressed a Liddle-disease channel mutation in Xenopus oocytes and demonstrated increased channel activity. This molecular experiment established a channel mechanism, not a screening rule for the far more common causes of ICU alkalosis. 10

Renin and aldosterone measurements therefore require attention to potassium concentration, sodium intake, effective filling, drugs, posture, and timing. A low potassium concentration can itself suppress aldosterone secretion, complicating interpretation. Hypertension or a relatively high urinary chloride may support a hypothesis but cannot independently identify the molecular or endocrine cause.

Congestive heart failure can produce elevated conservation signals alongside total fluid excess. Sodium retention then has a different context from an uncomplicated mineralocorticoid syndrome. Similar laboratory patterns do not establish equivalent circulatory conditions.

55.9 Posthypercapnic Alkalosis Reflects a Changing Reference State

Sustained carbon dioxide retention produces chemical buffering and renal adaptations that increase bicarbonate availability. When PaCO₂ falls, the previously adapted bicarbonate state can become alkalinizing relative to the new carbon dioxide tension. The respiratory perturbation can change faster than renal bicarbonate disposal and associated electrolyte balances recover.

An illustrative calculation isolates this transition. Assume bicarbonate of 36 mmol/L and PaCO₂ of 60 mmHg at the stated 37°C approximation. Dissolved carbon dioxide is 0.03 × 60 = 1.8 mmol/L, so pH is 6.1 + log₁₀(36 ÷ 1.8) ≈ 7.40.

If PaCO₂ becomes 40 mmHg while bicarbonate is deliberately held at 36 for the model, the denominator becomes 0.03 × 40 = 1.2 mmol/L. The ratio is 30 and pH is 6.1 + log₁₀(30) ≈ 7.58. This demonstrates the direction of the change; actual acute buffering would alter bicarbonate, and neither pressure is a ventilation target.

Schwartz and colleagues followed recovery after prolonged experimental hypercapnia in dogs. Chloride availability influenced the persistence and resolution of the increased bicarbonate state after return to room air. The preparation identifies a maintenance interaction beyond simply waiting for a previous renal adaptation to disappear; it does not prescribe a human carbon dioxide correction schedule. 11

In critical illness, simultaneous diuretic exposure, gastric drainage, potassium depletion, reduced filtration, and impaired chloride delivery can prolong the state. Persisting bicarbonate therefore need not represent an isolated renal memory of hypercapnia. The preceding acid–base course and the current maintenance mechanisms both matter.

The term posthypercapnic identifies timing and origin, but it should not replace assessment of ongoing losses and transport. Likewise, an alkalinizing transition does not prove that carbon dioxide should be restored to its earlier value. Respiratory support has independent consequences for gas exchange, effort, and circulation, developed in Chapter 56.

55.10 Urine Chloride Describes Current Handling and Requires Timing

Urine chloride is useful because chloride conservation and loss often distinguish maintenance environments. A kidney conserving chloride during external depletion differs from one continuing to excrete chloride through active diuretic effects, impaired transport, or mineralocorticoid-associated conditions. The distinction is conditional rather than a complete diagnosis from one concentration.

Pair concentration with flow before estimating loss:

U_Cl is chloride concentration in mmol/L. If representative urine contains 25 mmol/L and volume is 0.5 L/day, excretion is 25 × 0.5 = 12.5 mmol/day. At the same concentration with 3 L/day, excretion is 25 × 3 = 75 mmol/day. The sixfold difference in loss is invisible in concentration alone.

These are separate illustrative states, not diagnostic boundaries or desired excretion rates. Collections need matched timing and completeness. A spot concentration can help characterize a phase, but it does not establish daily chloride balance without representative flow and knowledge of inputs and nonrenal losses.

Recent diuretic exposure is particularly important. Active blockade can raise chloride excretion in a depleted patient; a later sample can show conservation after the effect wanes. Repeated measurements interpreted against drug timing can therefore reveal a sequence that one result conceals. Persistent renal chloride loss has other possible causes, including inherited or acquired tubular dysfunction.

Urinary sodium can diverge from chloride when bicarbonate or other anions accompany sodium. High urinary sodium during bicarbonaturia does not necessarily exclude chloride conservation. Urine pH adds another variable but does not quantify bicarbonate or net acid excretion by itself.

Neither urinary chloride nor its trend measures fluid responsiveness or tolerance. Low chloride excretion may coexist with edema and low effective arterial filling; a higher value does not certify intravascular excess or exclude external depletion. The useful question is whether current renal handling fits the proposed mechanism, not whether a concentration selects one universal fluid intervention.

55.11 Respiratory and Cellular Consequences Do Not Establish an Outcome Benefit from Correction

An alkalinizing state often reduces ventilatory drive, allowing PaCO₂ to rise and limiting the pH increase. The response depends on respiratory control, oxygenation, mechanics, muscle function, and concurrent neurological or pulmonary disease. It is not a fixed physical consequence of each increment in bicarbonate.

Goldring and colleagues induced chronic metabolic alkalosis under controlled conditions in human volunteers. Ventilatory responses differed with the method of induction despite comparable extracellular alkalosis. The observations caution against assuming that every alkalotic patient has the same depression of ventilation or that a bicarbonate value alone predicts PaCO₂. Detailed respiratory compensation and mixed-process interpretation follow in Chapters 56 and 57. 12

Alkalemia also changes protein charge and ion binding. Increased albumin binding can reduce ionized calcium without an equivalent change in total calcium, while associated potassium and magnesium abnormalities influence excitability and repolarization. Oxygen affinity and intracellular enzyme conditions can change as well. Their clinical importance depends on degree, duration, associated deficits, perfusion, and the underlying disease.

These mechanisms provide reasons to investigate and address a disturbance, but they do not prove that every intervention lowering bicarbonate improves recovery. A patient struggling to breathe may have mechanical load, weakness, sedation, cardiac dysfunction, and persistent lung disease in addition to an acid–base contribution.

DIABOLO tested acetazolamide against placebo in mechanically ventilated patients with chronic obstructive pulmonary disease and metabolic alkalosis. Bicarbonate and days with alkalosis decreased more with acetazolamide, but the primary comparison did not show a statistically significant reduction in invasive ventilation duration. The confidence interval retained uncertainty about clinically relevant benefit. This was a selected population and treatment strategy, not proof that alkalosis has no respiratory effects or that biochemical correction universally improves weaning. 13

The physiological endpoint and clinical endpoint must remain separate. Improvement in pH, potassium, or bicarbonate can be measured directly, while symptom recovery, ventilation duration, and survival require their own evidence and depend on several concurrent processes.

55.12 Integrate the Generator, Maintenance Mechanisms, and Measured Fluxes

Consider an illustrative patient with recent gastric drainage and loop exposure. Bicarbonate is 38 mmol/L and PaCO₂ is 52 mmHg. Using the stated approximation, dissolved carbon dioxide is 0.03 × 52 = 1.56 mmol/L and pH is 6.1 + log₁₀(38 ÷ 1.56) ≈ 7.49. This describes the supplied state without deciding whether the respiratory response is expected or whether another process coexists.

Over a representative day, absorbed or parenteral chloride input is 70 mmol. Gastric chloride loss is measured as 80 mmol, while complete urine contains 12 mmol/L at 1.5 L/day. Renal loss is 12 × 1.5 = 18 mmol, giving chloride balance 70 − 80 − 18 = −28 mmol/day. The kidney is losing an additional amount despite the external loss; its concentration alone does not calculate the existing deficit.

For a separate potassium balance during the same interval, input is 40 mmol, urinary loss 50 mmol, and gastrointestinal loss 10 mmol. Net potassium balance is 40 − 50 − 10 = −20 mmol/day. A serum potassium trajectory may differ because of redistribution. These assumed numbers teach accounting and do not prescribe replacement quantities.

The gastric loss supplies a plausible generator. Negative chloride and potassium balances, reduced effective filling, altered filtration, and distal transport can maintain the disturbance. Recent drug exposure changes how the urine result is interpreted. If drainage stops but bicarbonate remains elevated, persistence does not by itself prove unrecognized continuing acid loss.

Serial assessment tests this explanation. Examine the timing of inputs and losses, drug action, arterial gas changes, renal function, and electrolyte trajectories. Determine whether bicarbonate disposal becomes possible as the maintenance conditions change. Circulatory and pulmonary assessment establish the tolerability of any associated sodium or water changes.

Explain origin, persistence, and direction over time, allowing several concurrent mechanisms. Treatment selection then rests on the verified cause and broader clinical state, rather than bicarbonate concentration or a urine chloride category alone.

References

1. Needle MA, Kaloyanides GJ, Schwartz WB. The effects of selective depletion of hydrochloric acid on acid–base and electrolyte equilibrium. J Clin Invest. 1964;43:1836–1846. doi:10.1172/JCI105057

2. Wilcox CS, Mitch WE, Kelly RA, et al. Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med. 1983;102:450–458. PubMed

3. Cogan MG, Liu FY. Metabolic alkalosis in the rat: evidence that reduced glomerular filtration rather than enhanced tubular bicarbonate reabsorption is responsible for maintaining the alkalotic state. J Clin Invest. 1983;71:1141–1160. doi:10.1172/JCI110864

4. Galla JH, Bonduris DN, Luke RG. Effects of chloride and extracellular fluid volume on bicarbonate reabsorption along the nephron in metabolic alkalosis in the rat: reassessment of the classical hypothesis of the pathogenesis of metabolic alkalosis. J Clin Invest. 1987;80:41–50. doi:10.1172/JCI113061

5. Rosen RA, Julian BA, Dubovsky EV, Galla JH, Luke RG. On the mechanism by which chloride corrects metabolic alkalosis in man. Am J Med. 1988;84:449–458. doi:10.1016/0002-9343(88)90265-3

6. Royaux IE, Wall SM, Karniski LP, et al. Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc Natl Acad Sci U S A. 2001;98:4221–4226. doi:10.1073/pnas.071516798

7. Jones JW, Sebastian A, Hulter HN, Schambelan M, Sutton JM, Biglieri EG. Systemic and renal acid–base effects of chronic dietary potassium depletion in humans. Kidney Int. 1982;21:402–410. doi:10.1038/ki.1982.36

8. Lee HW, Harris AN, Wall SM, Weiner ID. Effects of proximal tubule NBCe1-A deletion on collecting duct intercalated cell responses to hypokalemia. Am J Physiol Renal Physiol. 2026;331:F22–F38. doi:10.1152/ajprenal.00043.2026

9. Kassirer JP, Appleton FM, Chazan JA, Schwartz WB. Aldosterone in metabolic alkalosis. J Clin Invest. 1967;46:1558–1571. doi:10.1172/JCI105647

10. Schild L, Canessa CM, Shimkets RA, Gautschi I, Lifton RP, Rossier BC. A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression system. Proc Natl Acad Sci U S A. 1995;92:5699–5703. doi:10.1073/pnas.92.12.5699

11. Schwartz WB, Hays RM, Polak A, Haynie GD. Effects of chronic hypercapnia on electrolyte and acid–base equilibrium. II. Recovery, with special reference to the influence of chloride intake. J Clin Invest. 1961;40:1238–1249. doi:10.1172/JCI104354

12. Goldring RM, Cannon PJ, Heinemann HO, Fishman AP. Respiratory adjustment to chronic metabolic alkalosis in man. J Clin Invest. 1968;47:188–202. doi:10.1172/JCI105708

13. Faisy C, Meziani F, Planquette B, et al. Effect of acetazolamide vs placebo on duration of invasive mechanical ventilation among patients with chronic obstructive pulmonary disease: a randomized clinical trial. JAMA. 2016;315:480–488. doi:10.1001/jama.2016.0019